Robert Joseph Smith - 14 Mar 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTXR	Stock Option (Right to Purchase Common Stock)	Award	$0	+75,000		$0.000000	75,000	14 Mar 2024	Common Stock	75,000	$0.6900	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options were granted on March 14, 2024, with a Vesting Commencement Date of March 12, 2024, the date of the Optionee's election to the Board of the Company. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.